Publication|Articles|December 18, 2024
- Pharmaceutical Executive: December 2024
- Volume 44
- Issue 12
Pharmaceutical Executive: December 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive December 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
11 months ago
Trending Forward11 months ago
Pharma’s ‘Best-Kept Secret’11 months ago
Seeking More Value, Less Cost11 months ago
Dealmaking Dormant No More11 months ago
A Rocky Road for Regulation11 months ago
DTC's New Era of Engagement11 months ago
Holding On Tight to AI WaveNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Targeting CCR5 Receptors
2
Merck to Acquire Cidara for $9.2 Billion
3
Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML
4
DEI Changes in Pharma: A Look Back at 2025 & Predictions for 2026
5
